Cell Cycle Arrest Effects of Large-Dose FTY720 on Lymphocytes in Mouse Skin Transplantation Models
Authors:
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 30 (2) , 365-381
Abstract
To probe into the mechanism of immunosuppression of FTY720, the authors study the cell cycle arrest effects of large-dose FTY720 on lymphocytes in mouse skin transplantation models and the expression of cell cycle–related factors in cell cycle regulation system in mouse skin allograft models using flow cytometry, Immunohistochemical staining, and reverse transcriptase–polymerase chain reaction (RT-PCR). FTY720 could prolong survival days of graft in mouse skin transplantation models obviously (p < 0.01). In thymus gland and lymph node, compared with the control group, cell percentage in G0-G1 increases and cell percentage in G2-M and S decreases in the treated group (p < 0.01). Expression of P16 increases and expression of cyclin D1 decreases in the treated group (p < 0.05). In thymus gland, it is shown by semiquantitative RT-PCR that the quantity of mRNA of P16 increases in the treated group (p < 0.01), and the quantity of mRNA of cyclin D1 decreases in the treated group (p < 0.01). FTY720 is a kind of effective immunosuppressant. FTY720 could induce cell cycle arrest in thymus gland and lymph node and change the expression of protein and the transcription of mRNA of cell cycle–related factor.Keywords
This publication has 29 references indexed in Scilit:
- Randomized Controlled Trial of FTY720 Versus MMF in De Novo Renal TransplantationTransplantation, 2006
- Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinomaMolecular Cancer Therapeutics, 2005
- FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylationCarcinogenesis, 2004
- FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populationsBritish Journal of Ophthalmology, 2004
- FTY720 MEDIATES APOPTOSIS-INDEPENDENT LYMPHOPENIA IN HUMAN RENAL ALLOGRAFT RECIPIENTS: DIFFERENT EFFECTS ON CD62L+ AND CCR5+ T LYMPHOCYTESTransplantation, 2004
- Role of extracellular regulated protein kinases in FTY720-induced apoptosis of leukemia cell lines HL-60 and U937Current Medical Science, 2004
- Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I studyTransplantation, 2003
- A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cellsBritish Journal of Pharmacology, 2003
- Coordinate Involvement of Cell Cycle Arrest and Apoptosis Strengthen the Effect of FTY720Japanese Journal of Cancer Research, 2001
- Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720Bioorganic & Medicinal Chemistry Letters, 1995